Progenics Pharmaceuticals 10K 2004 Annual report | PGNX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	7th grade Avg

New words: Abbott, absent, absolute, accretion, accurately, advisor, AG, age, Altana, Alton, Amherst, Arbitrage, auction, Baltimore, bankruptcy, billed, bioMerieux, buy, Cayman, chairmanship, Charter, circumvented, closer, collusion, Commerce, compelling, COSO, curtailing, Danmark, Denison, deploying, detect, detected, detection, Deutsche, DF, diligence, disability, disposition, dispositive, dissolve, dissolved, Diversified, diversify, Dragic, Eastview, Ecole, Elizabeth, EnteregTM, entereg™, evenly, evidenced, excise, expeditiously, expert, expressly, fiduciary, fifty, fill, Finsbury, FLAIR, foregoing, forgiven, Foster, fot, France, franchise, front, fullest, Galenica, Goldman, gradually, graph, Gymnasium, halt, halted, Hammer, Hematopoietic, HFR, hypothetical, Immunochemistry, implied, improper, inability, inactivated, inconsistent, indirectly, infrastructure, input, insolvency, intent, intention, Isaly, Janssen, jeopardize, judged, Kidder, Kilkenny, Knightsbridge, Korsant, Kremer, Lausanne, leadership, likeliest, Liposome, liter, loan, LP, lump, Mallinckrodt, maximizing, meaningful, mechanism, membership, metastatic, Michael, Mill, mindful, mitigate, modest, NASD, necessarily, NOL, Nominating, Nordisk, notified, Novo, occupy, OrbiMed, override, Overview, owner, package, PaineWebber, parachute, PBK, Peabody, pecuniary, peer, pertain, Pharma, Pharmaceutica, philosophy, possession, predetermined, preserve, Princeton, proceed, processed, promissory, properly, prostatectomy, qualitative, quickly, radioisotope, rarely, reclassified, recordkeeping, recovered, Regeneron, release, repayment, resale, rescue, reset, resignation, resigned, resold, retroactive, reward, River, Road, rolling, salalry, salaried, salary, Scott, Searle, Secondary, sentence, session, SHC, shelf, silence, slower, specialty, spouse, staffed, standing, Stanford, straight, strike, subscription, substantive, substitution, sum, supplier, suspension, Swarthmore, TAP, Tatjana, TGH, TGT, thereunder, thirty, TIC, Topanga, TPT, trauma, Treadway, trust, UBS, vacated, Vanderbilt, variation, voluntarily, Walsh, Wesleyan, XIII, Yeshiva, Ziff

Removed: abandonment, ABX, Academy, acted, acting, acute, admitted, adult, Allergy, ambulatory, analyze, anticipation, antiretroviral, apparent, approach, approximating, assisting, auditing, AVRV, AVX, Baylor, blocked, BMS, California, Cardiovascular, career, carrier, cellular, children, cocktail, collaborated, combined, composed, composition, conflict, conform, considerably, constant, constructed, cooperation, correlated, counsel, created, creation, dedicated, Detroit, Diagnostic, differentiation, dilutive, discovered, discrete, drawback, elimination, enhanced, entering, entertainment, envelope, Eradication, evade, exacerbated, execution, expending, favorably, FD, flexibility, forward, Francisco, frequency, guaranteed, hard, healthcare, hemocyanin, hidden, higher, highest, holder, Houston, hundred, impossible, indefinitely, inhibited, inhibition, inhibitor, inhibitory, injection, instrument, interaction, invalidation, ix, journal, keyhole, KLH, leased, leave, limpet, margin, measured, metastasize, Millennium, Mount, murine, mutual, mutually, NCI, neutralization, occult, original, panel, parallel, peak, Pediatric, penetration, Pharmacokinetic, Political, poor, potently, precautionary, predecessor, predominate, producing, profit, prolong, prolonged, prostectomy, protecting, publication, published, ratably, region, reimburse, reliance, relinquished, remained, residual, San, screen, Secretary, selecting, sequence, serum, servicing, show, Sinai, Southwest, spent, Sterling, suitable, sun, supported, susceptible, sustained, SWOG, synergistic, synergistically, temporarily, transmission, triple, turn, typical, ultraviolet, Unamortized, undisclosed, unsafe, upfront, usage, utilized, vaccination, varying, vast, viii, vital, vivo, Warrant, Winthrop

Name	Title	2005 Salary	Cash Bonus
Paul J. Maddon, M.D., Ph.D.	Chief Executive Officer and Chief Science Officer	$536,785	$150,000
Robert J. Israel, M.D.	Senior Vice President, Medical Affairs	312,000	50,000
Robert A. McKinney	Chief Financial Officer, Vice President, Finance and Operations and Treasurer	230,000	60,000
Ronald J. Prentki⁽¹⁾	President and Director	385,650	75,000

Progenics Pharmaceuticals (PGNX) 10-K2004 FY Annual report

Content analysis